Skip to content

Leigh Berrien, APRN

NPI 1134998230ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· New Haven, CT

Internal Medicine, Endocrinology, Diabetes & Metabolism (APRN) in New Haven, Connecticut, licensed in CT, with an NPI issued in December 2023. Novo Nordisk Inc reported $30.41 in payments in 2025, mostly food and beverage.

Overview

NPI1134998230
StatusActive
Entity typeIndividual
CredentialAPRN
Sole proprietorYes
NPI issuedDec 29, 2023
Last updated in NPPESJan 8, 2024
Certified by providerJan 5, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$30.41 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$30.411

What the 2025 payments were for

  • Food and Beverage$30.41 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New Haven

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Connecticut →